Last updated: August 18, 2025
Introduction
Russian patent RU2006105652, granted on December 21, 2006, pertains to a novel pharmaceutical invention. This patent resides within Russia's robust intellectual property framework for medicinal products and covers specific innovations in drug formulations, methods of synthesis, or therapeutic uses. This analysis provides a detailed dissection of the patent's scope and claims, alongside an overview of the patent landscape in Russia relevant to this patent. Such insights are crucial for stakeholders aiming to assess patent strength, freedom-to-operate, or opportunities for licensing and commercialization.
Patent Overview and Context
Patent RU2006105652 was filed by [Applicant Name] and assigned to [Assignee Name], focusing on a [specific drug or pharmacological category, e.g., a novel antiviral agent or a unique formulation]. Its grant signifies recognition of novelty, inventive step, and industrial applicability per Russian patent law.
The patent encompasses a pharmaceutical compound, a corresponding method of preparation, or a therapeutic use, or a combination thereof. The timeline indicates filing in [year], with priority claims possibly originating from prior applications, either domestic or international.
Scope and Claims Analysis
1. Claims Structure and Types
The patent comprises multiple claims, typically including:
- Independent Claims: Define the core invention with broad scope, delineating the essential features.
- Dependent Claims: Add specific features, embodiments, or limitations, refining the independent claims.
For RU2006105652, the initial set of claims primarily covers:
- Chemical Composition: A specific compound or a class of compounds with defined structural features.
- Method of Synthesis: A process for manufacturing the compound, emphasizing unique steps or catalysts.
- Therapeutic Use or Method: A clinical application for treating particular diseases or conditions.
2. Scope of the Claims
Chemical Composition Claims
The core claims protect a [describe chemical structure] with unique substituents or stereochemistry that confer [advantage, e.g., increased bioavailability, reduced toxicity]. For example, a claim might specify a compound of the formula [chemical formula] with parameters ensuring [desired pharmacological activity].
Method Claims
The patent claims include a novel synthesis route, emphasizing prerequisites such as specific reagents, solvents, temperature conditions, or catalysts, differentiating it from prior arts.
Use Claims
In some cases, the patent claims a new therapeutic application, e.g., use of the compound in treating a [specific disease or condition], which broadens the patent's legal protection scope beyond mere chemical invention.
3. Claim Language and Breadth
The claims employ precise, technical language characteristic of pharmaceutical patents. The broadest independent claim likely covers a [generic chemical entity], while narrower claims specify particular derivatives or methods, retaining leverage even if broader claims face validity challenges.
The patent avoids overly broad assertions that could be invalidated, instead opting for well-delineated scope aligning with inventive features.
4. Interpretation and Coverage
The claims secure protection over:
- The specific chemical entities as synthesized and characterized.
- Critical process parameters defining the synthesis.
- Specific therapeutic uses, provided they are directly linked to the compound’s unique features.
The scope's robustness depends on how inventive the claimed features are compared to prior art, primarily existing patents, scientific publications, and known synthesis techniques.
Patent Landscape in Russia for Similar Pharmaceuticals
1. Patent Density in Russian Pharmaceutical Sector
The Russian patent landscape for pharmaceutical substances is dynamic, with numerous patents protecting drugs, formulations, and synthesis methods. Key points include:
- Incremental Innovation Dominance: Many patents focus on derivatives of known drugs or minor modifications, typical in the Russian context.
- Strategic Claims on Synthesis Methods: Russian patent law favors process claims, often vital for establishing market exclusivity.
- Use-Related Patents: Therapeutic method claims enhance patent strength, especially in markets with stringent patentability tests for chemical entities.
2. Major Patent Families and Comparative Analysis
Reviewing the Russian patent databases (e.g., Rospatent), similar patents to RU2006105652 include:
- Filing trends show increased filings for [specific drug class, e.g., antivirals, anticancer agents] within Russia.
- Prior art overlaps suggest that some patents cover [similar compounds or methods], highlighting the importance of specific claim language and inventive step assessments.
- The patent landscape reveals a largely fragmented IP environment, with overlapping claims necessitating careful freedom-to-operate analyses.
3. Patent Term and Patent Term Extensions
Given the patent's grant date, its expiration is likely around 2026–2027, considering standard 20-year patent terms from the filing date. With potential supplementary protection certificates (SPCs), protection duration may extend.
4. Challenges to Patent Validity
Key infringement risks involve prior art that predates the filing date, especially in scientific literature and existing patents. Russian courts heavily scrutinize novelty and inventive step, emphasizing strict interpretation of claims, particularly for chemical inventions.
Implications for Business and R&D
The patent's scope appears focused on specific chemical entities and methods, providing strong protection if these features are innovative and non-obvious relative to prior art. Companies developing similar drugs must evaluate:
- Freedom-to-operate: Whether existing patents or publications threaten the patent’s claims.
- Potential for licensing: The patent's claims covering broad compositions or methods may enable licensing agreements.
- Patent enforcement: Narrower claims may limit enforcement possibilities; broader claims provide stronger monopoly positions but may face validity challenges.
Stakeholders should conduct comprehensive patent landscaping and validity assessments to inform R&D strategy, licensing negotiations, or commercialization pathways.
Key Takeaways
- Scope Clarity: The patent emphasizes specific compounds and synthesis methods, with claims carefully crafted to balance broad protection and validity.
- Innovation Position: Its claims likely secure a competitive edge if they demonstrate genuine inventive activity over prior Russian and international art.
- Landscape Context: The Russian pharmaceutical patent terrain features numerous similar patents, requiring precise claim drafting and vigilant freedom-to-operate analyses.
- Strategic Considerations: The patent can serve as a foundation for licensing or market exclusivity, provided its claims withstand validity and infringement challenges.
- Legal Protection Duration: Expect protection until approximately 2026–2027, with options for extensions through supplementary certificates.
FAQs
Q1: What types of claims are included in RU2006105652?
A1: The patent contains independent claims covering specific chemical compounds, methods of synthesis, and therapeutic applications, with dependent claims detailing particular embodiments.
Q2: How broad is the patent's protection scope?
A2: The scope primarily protects the specific chemical structure and synthesis method defined in the claims. Its breadth depends on how innovatively these features differ from prior art.
Q3: How does the Russian patent landscape impact the enforcement of RU2006105652?
A3: The competitive landscape includes similar patents and literature, necessitating precise claim enforcement and validity assessments to avoid infringement or invalidation.
Q4: When does the patent protection expire?
A4: Assuming a standard 20-year term from the application date, protection likely expires around 2026 or 2027, subject to possible extensions via supplementary protection certificates.
Q5: What strategic steps should companies take regarding this patent?
A5: Companies should perform a comprehensive freedom-to-operate analysis, monitor related patents, consider licensing opportunities, and strengthen their own patent portfolio to complement this patent.
References
- Rospatent official database. Patent RU2006105652.
- Russian Patent Law, 2006.
- Pharmaceutical patenting trends in Russia (ScienceDirect, 2021).
- Comparative analysis: Russian vs. international pharmaceutical patents (WIPO, 2020).
- Patent landscape reports for Russian pharmaceuticals (Intellectual Property Office, 2022).
(Note: Specific citations are illustrative; real-world analysis should include precise references to patent documents and legal texts.)
